REGN — Recent News Coverage
All news mentioning REGN in ESEN's AI-graded feed
News stories with REGN as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on REGN. See /coverage/REGN for the 30-day aggregate.
MANILATIMES.NET
·
2026-07-01
NEUTRAL
BULLISH
CORR0.45
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
$HROW
$REGN
◈ ESEN AI
Harrow Health (HROW) announced commercial availability of BYOOVIZ®, a ranibizumab biosimilar targeting retinal disease treatment in the U.S. market. This launch expands the company's existing retina-focused portfolio an…
FINANCE.YAHOO.COM
·
2026-06-30
NEUTRAL
NEUTRAL
CORR0.15
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
$REGN
◈ ESEN AI
Talawar Therapeutics is entering the public markets via Nasdaq IPO with $285 million in capital, positioning itself as a competitor to Regeneron's blockbuster Dupixent in the eczema therapeutic space. This represents st…
CNBC
·
2026-06-29
NEUTRAL
BULLISH
CORR0.42
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
$LLY
$REGN
◈ ESEN AI
Eli Lilly and Regeneron have been selected as pilot participants in the FDA's PreCheck Pilot Program, a regulatory initiative designed to accelerate facility reviews for pharmaceutical manufacturing. This selection amon…
INSIDERMONKEY.COM
·
2026-06-28
NEUTRAL
BULLISH
CORR0.52
Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?
$REGN
◈ ESEN AI
Regeneron Pharmaceuticals (REGN) achieved a regulatory milestone on June 22 when both the FDA and European Medicines Agency accepted applications for cemdisiran, a therapeutic candidate. This dual regulatory acceptance …
INVESTORIDEAS.COM
·
2026-06-26
HIGH
BULLISH
CORR0.72
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance
$SNGX
$AEMD
$REGN
$MRNA
◈ ESEN AI
A global Ebola outbreak in 2026 has triggered accelerated development across the biotech sector, with specialized players SNGX, AEMD, REGN, and MRNA mobilizing vaccine, antibody, and therapeutic platforms against Bundib…
MANILATIMES.NET
·
2026-06-22
NEUTRAL
BULLISH
CORR0.35
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
$REGN
◈ ESEN AI
Regeneron Pharmaceuticals (REGN) has achieved a regulatory milestone with FDA and EMA acceptance of cemdisiran submissions for generalized myasthenia gravis (gMG), a rare neuromuscular disorder. This represents progress…
SEEKINGALPHA.COM
·
2026-06-12
NEUTRAL
NEUTRAL
CORR0.35
Regeneron Pharmaceuticals, Inc. (REGN) Shareholder/Analyst Call - Slideshow (NASDAQ:REGN) 2026-06-12
$REGN
◈ ESEN AI
REGN published investor-relations materials via a shareholder and analyst call slideshow, a routine disclosure mechanism typical of quarterly or ad-hoc communication cycles. The absence of specific operational metrics, …
INSIDERMONKEY.COM
·
2026-06-11
LOW
NEUTRAL
CORR0.42
Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now?
$REGN
◈ ESEN AI
Regeneron Pharmaceuticals (REGN) is the subject of a bullish investment thesis circulating in retail investor forums. The article presents user-generated commentary on the stock's investment merits, reflecting emerging …
EXPLORE OTHER FILTERS